
RICFY
Healthcare · Drug Manufacturers - General · $11.99B market cap
$14.40-0.08 (-0.6%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 7, 2025 | Before the open | — | 0.16 | — |
| Nov 8, 2024 | Before the open | — | 0.15 | — |
| Jul 30, 2024 | Before the open | — | 0.13 | — |
| May 9, 2024 | Before the open | — | 0.16 | — |
| Feb 22, 2024 | Before the open | — | 0.11 | — |
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for…